{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:31:54Z","timestamp":1781508714938,"version":"3.54.1"},"reference-count":123,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,8,30]],"date-time":"2015-08-30T00:00:00Z","timestamp":1440892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,8,30]],"date-time":"2015-08-30T00:00:00Z","timestamp":1440892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1111\/bjd.13956","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T17:31:49Z","timestamp":1434994309000},"page":"651-662","source":"Crossref","is-referenced-by-count":26,"title":["Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments"],"prefix":"10.1093","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-0182","authenticated-orcid":false,"given":"E.J.","family":"van Zuuren","sequence":"first","affiliation":[{"name":"Department of Dermatology B1-Q; Leiden University Medical Centre; PO Box\u00a09600 2300 RC Leiden 2333 ZA the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Fedorowicz","sequence":"additional","affiliation":[{"name":"Bahrain Branch; Cochrane; Awali Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,8,30]]},"reference":[{"key":"10.1111\/bjd.13956-BIB0001|bjd13956-cit-0001","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0002|bjd13956-cit-0002","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12385","article-title":"An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes","volume":"169","author":"Tan","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0003|bjd13956-cit-0003","first-page":"16","article-title":"Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema","volume":"5","author":"Del Rosso","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"issue":"Suppl. 3","key":"10.1111\/bjd.13956-BIB0004|bjd13956-cit-0004","first-page":"1","article-title":"An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea","volume":"91","author":"Del Rosso","year":"2013a","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0005|bjd13956-cit-0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","article-title":"Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group","volume":"25","author":"Elewski","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13956-BIB0006|bjd13956-cit-0006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13956-BIB0007|bjd13956-cit-0007","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jaad.2013.04.045","article-title":"New insights into rosacea pathophysiology: a review of recent findings","volume":"69","author":"Steinhoff","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0008|bjd13956-cit-0008","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"10.1111\/bjd.13956-BIB0009|bjd13956-cit-0009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/jidsymp.2011.4","article-title":"Rosacea as a disease of cathelicidins and skin innate immunity","volume":"15","author":"Yamasaki","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.13956-BIB0010|bjd13956-cit-0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2010.09894.x","article-title":"The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities","volume":"163","author":"Aksoy","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0011|bjd13956-cit-0011","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2340\/00015555-1976","article-title":"Health-related quality of life in patients with cutaneous rosacea: a systematic review","volume":"95","author":"Linden","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.13956-BIB0012|bjd13956-cit-0012","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2133.2011.10473.x","article-title":"Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review","volume":"165","author":"Zuuren","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0013|bjd13956-cit-0013","first-page":"CD003262","article-title":"Interventions for rosacea","volume":"4","author":"Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.13956-BIB0014|bjd13956-cit-0014","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 2011 www.cochrane-handbook.org"},{"key":"10.1111\/bjd.13956-BIB0015|bjd13956-cit-0015","unstructured":"Review Manager (RevMan) [computer program] 5.3 Copenhagen The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1111\/bjd.13956-BIB0016|bjd13956-cit-0016","unstructured":"Sch\u00fcnemann H Brozek J Guyatt G Oxman A GRADE handbook for grading quality of evidence and strength of recommendation. Updated October 2013. The GRADE working Group 2013 http:\/\/www.guidelinedevelopment.org\/handbook\/"},{"key":"10.1111\/bjd.13956-BIB0017|bjd13956-cit-0017","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjd.12881","article-title":"Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea","volume":"171","author":"Benkali","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0018|bjd13956-cit-0018","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2340\/0001555564358359","article-title":"Topical treatment with sulfur 10 per cent for rosacea","volume":"64","author":"Blom","year":"1984","journal-title":"Acta Derm Venereol"},{"issue":"Suppl. 25","key":"10.1111\/bjd.13956-BIB0019|bjd13956-cit-0019","first-page":"43","article-title":"Skin barrier function assessment by in\u00a0vivo confocal microscopy and other non-invasive optical measurements on patients suffering from rosacea to evaluate the efficacy of a post-laser serum","volume":"45","author":"Buendia-Bordera","year":"2013","journal-title":"Lasers Surg Med"},{"key":"10.1111\/bjd.13956-BIB0020|bjd13956-cit-0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1473-2165.2006.00219.x","article-title":"An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients","volume":"5","author":"Draelos","year":"2006","journal-title":"J Cosmet Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13956-BIB0021|bjd13956-cit-0021","first-page":"AB82","article-title":"Facial foundation with niacinamide and N-acetylglucosamine improves skin condition in women with sensitive skin","volume":"60","author":"Draelos","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0022|bjd13956-cit-0022","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jocd.12061","article-title":"Hydrophobically modified polymers can minimize skin irritation potential caused by surfactant-based cleansers","volume":"12","author":"Draelos","year":"2013a","journal-title":"J Cosmet Dermatol"},{"key":"10.1111\/bjd.13956-BIB0023|bjd13956-cit-0023","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archderm.1994.01690030051008","article-title":"A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea","volume":"130","author":"Ertl","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13956-BIB0024|bjd13956-cit-0024","first-page":"129","article-title":"Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea","volume":"120","author":"Espagne","year":"1993","journal-title":"Ann Dermatol Venereol"},{"issue":"Suppl. 23","key":"10.1111\/bjd.13956-BIB0025|bjd13956-cit-0025","first-page":"968","article-title":"Combination 15% azelaic acid gel and intense pulse light therapy for mild to moderate rosacea","volume":"43","author":"Fabi","year":"2011","journal-title":"Lasers Surg Med"},{"issue":"Suppl.","key":"10.1111\/bjd.13956-BIB0026|bjd13956-cit-0026","first-page":"S145","article-title":"Metronidazole 0.75% gel and lotion are both effective in the treatment of rosacea","volume":"12","author":"Guillet","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13956-BIB0027|bjd13956-cit-0027","first-page":"AB9","article-title":"Multicenter, randomized, double-blind, placebo-controlled evaluation of rosacea related inflammatory biomarkers in papulopustular rosacea adults treated with doxycycline 40\u00a0mg modified release","volume":"70","author":"Huang","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0028|bjd13956-cit-0028","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0190-9622(98)70337-8","article-title":"The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double blind clinical trial","volume":"39","author":"Jorizzo","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13956-BIB0029|bjd13956-cit-0029","first-page":"AB43","article-title":"Evaluation of the safety and effectiveness of microfocused ultrasound with visualization (MFU-V) for the treatment of erythematotelangiectatic rosacea","volume":"70","author":"Lupin","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0030|bjd13956-cit-0030","unstructured":"NCT00249782. A phase II, randomized, partial-blind, parallel-group, active- and vehicle-controlled, multicenter study of the safety and efficacy of ACZONE\u2122 (dapsone) gel, 5% in subjects with papulopustular rosacea"},{"issue":"Suppl.","key":"10.1111\/bjd.13956-BIB0031|bjd13956-cit-0031","first-page":"AB64","article-title":"A double-blind, placebo-controlled study of a natural anti-inflammatory for treatment of rosacea","volume":"54","author":"Rehmus","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13956-BIB0032|bjd13956-cit-0032","first-page":"17","article-title":"Efficacy and safety of subantimicrobial-dose doxycycline for the treatment of rosacea","volume":"52","author":"Thiboutot","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0033|bjd13956-cit-0033","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1468-3083.1997.tb00469.x","article-title":"Treatment of rosacea with ketoconazole","volume":"8","author":"Uta\u015f","year":"1997","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13956-BIB0034|bjd13956-cit-0034","first-page":"729","article-title":"Treatment of rosacea. Clonidine (0.075\u00a0mg per day) versus placebo (initial results)","volume":"124","author":"Van Landuyt","year":"1997","journal-title":"Ann Dermatol Venereol"},{"issue":"Pt 1","key":"10.1111\/bjd.13956-BIB0035|bjd13956-cit-0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0190-9622(89)70022-0","article-title":"Effect of nadolol on flushing reactions in rosacea","volume":"20","author":"Wilkin","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0036|bjd13956-cit-0036","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-4362.1993.tb00974.x","article-title":"Treatment of rosacea: topical clindamycin versus oral tetracycline","volume":"32","author":"Wilkin","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0037|bjd13956-cit-0037","article-title":"Efficacy of cyclosporine A for the treatment of ocular rosacea","volume":"46","author":"Wittpenn","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl. 23","key":"10.1111\/bjd.13956-BIB0038|bjd13956-cit-0038","first-page":"918","article-title":"Combination therapy for the treatment of erythematotelangiectatic rosacea","volume":"43","author":"Yoo","year":"2011","journal-title":"Lasers Surg Med"},{"key":"10.1111\/bjd.13956-BIB0039|bjd13956-cit-0039","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0040|bjd13956-cit-0040","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mjd.2003.308","article-title":"Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from 2 vehicle-controlled, randomized phase III studies","volume":"48","author":"Thiboutot","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0041|bjd13956-cit-0041","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","article-title":"Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial","volume":"47","author":"Akhyani","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0042|bjd13956-cit-0042","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archderm.135.6.659","article-title":"Effect of treatment of Helicobacter pylori infection on rosacea","volume":"135","author":"Bamford","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13956-BIB0043|bjd13956-cit-0043","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/S0161-6420(96)30412-0","article-title":"The efficacy of topical metronidazole in the treatment of ocular rosacea","volume":"103","author":"Barnhorst","year":"1996","journal-title":"Ophthalmology"},{"issue":"Suppl. 3","key":"10.1111\/bjd.13956-BIB0044|bjd13956-cit-0044","first-page":"P10","article-title":"A multi-center, investigator-blind clinical trial to assess the safety and efficacy of metronidazole gel 1% as compared to metronidazole gel vehicle and metronidazole cream 1% in the treatment of rosacea","volume":"52","author":"Beutner","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0045|bjd13956-cit-0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF03259203","article-title":"A double-blind randomised study of metronidazole (Flagyl) 1% cream in the treatment of acne rosacea, a placebo controlled study","volume":"2","author":"Bitar","year":"1990","journal-title":"Drug Invest"},{"key":"10.1111\/bjd.13956-BIB0046|bjd13956-cit-0046","first-page":"187","article-title":"Metronidazole (Elyzol) 1% cream vs. placebo cream in the treatment of rosacea","volume":"26","author":"Bjerke","year":"1989","journal-title":"Clin Trials J"},{"key":"10.1111\/bjd.13956-BIB0047|bjd13956-cit-0047","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/000155599750009906","article-title":"Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea","volume":"79","author":"Bjerke","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.13956-BIB0048|bjd13956-cit-0048","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.1987.01660290077020","article-title":"Topical metronidazole therapy for rosacea","volume":"123","author":"Bleicher","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13956-BIB0049|bjd13956-cit-0049","first-page":"44","article-title":"A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea","volume":"61","author":"Breneman","year":"1998","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0050|bjd13956-cit-0050","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-4632.2004.02283.x","article-title":"Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide\/clindamycin topical gel in the treatment of moderate to severe rosacea","volume":"43","author":"Breneman","year":"2004","journal-title":"Int J Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13956-BIB0051|bjd13956-cit-0051","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.3109\/09546639309082150","article-title":"Topical azelaic acid in the treatment of rosacea","volume":"4","author":"Carmichael","year":"1993","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.13956-BIB0052|bjd13956-cit-0052","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archderm.134.6.679","article-title":"Topical metronidazole maintains remissions of rosacea","volume":"134","author":"Dahl","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13956-BIB0053|bjd13956-cit-0053","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1067\/mjd.2001.116219","article-title":"Once-daily topical metronidazole cream formulations in the treatment of papules and pustules of rosacea","volume":"45","author":"Dahl","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0054|bjd13956-cit-0054","first-page":"573","article-title":"Comparison of anti-inflammatory dose doxycycline versus doxycycline 100\u00a0mg in the treatment of rosacea","volume":"7","author":"Del Rosso","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"7 Pt 2","key":"10.1111\/bjd.13956-BIB0055|bjd13956-cit-0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1524-4725.2005.31735","article-title":"Efficacy of 1% 4-ethoxybenzaldehyde in reducing facial erythema","volume":"31","author":"Draelos","year":"2005","journal-title":"Dermatol Surg"},{"issue":"Suppl. 2","key":"10.1111\/bjd.13956-BIB0056|bjd13956-cit-0056","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0926-9959(98)95615-X","article-title":"Comparison of the clinical efficacy and safety of metronidazole 0.75% cream with metronidazole 0.75% gel in the treatment of rosacea","volume":"11","author":"Dreno","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13956-BIB0057|bjd13956-cit-0057","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","article-title":"A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial","volume":"139","author":"Elewski","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13956-BIB0058|bjd13956-cit-0058","first-page":"641","article-title":"Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea","volume":"6","author":"Fowler","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0059|bjd13956-cit-0059","first-page":"687","article-title":"Rilmenidine in rosacea: a double blind study versus placebo","volume":"124","author":"Grosshans","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/bjd.13956-BIB0060|bjd13956-cit-0060","first-page":"702","article-title":"Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064\u00a0nm): a randomized controlled trial with blinded response evaluation","volume":"34","author":"Karsai","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.13956-BIB0061|bjd13956-cit-0061","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2230.2009.03427.x","article-title":"A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial","volume":"35","author":"Koca","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"Suppl. 32","key":"10.1111\/bjd.13956-BIB0062|bjd13956-cit-0062","first-page":"S143","article-title":"Dark sulfonated shale oil versus placebo in the systemic treatment of rosacea","volume":"12","author":"Koch","year":"1999","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"10.1111\/bjd.13956-BIB0063|bjd13956-cit-0063","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000065849","article-title":"Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea","volume":"205","author":"Ko\u00e7ak","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13956-BIB0064|bjd13956-cit-0064","first-page":"183","article-title":"The comparative efficacy of sodium sulfacetamide 10%\/sulfur 5% (Sulfacet-R) lotion and metronidazole 0.75% (Metrogel) in the treatment of rosacea","volume":"3","author":"Lebwohl","year":"1995","journal-title":"J Geriatr Dermatol"},{"issue":"6 Pt 1","key":"10.1111\/bjd.13956-BIB0065|bjd13956-cit-0065","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","article-title":"A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea","volume":"40","author":"Maddin","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0066|bjd13956-cit-0066","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(71)90376-X","article-title":"Comparative effectiveness of tetracycline and ampicillin in rosacea: a controlled trial","volume":"2","author":"Marks","year":"1971","journal-title":"Lancet"},{"key":"10.1111\/bjd.13956-BIB0067|bjd13956-cit-0067","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09546639109092728","article-title":"Topical metronidazole in the treatment of rosacea","volume":"2","author":"Monk","year":"1991","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.13956-BIB0068|bjd13956-cit-0068","first-page":"185","article-title":"Topical treatment of acne rosacea with benzoyl peroxide acetone gel","volume":"32","author":"Montes","year":"1983","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0069|bjd13956-cit-0069","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2008.02940.x","article-title":"Comparative study of some treatment modalities of rosacea","volume":"23","author":"Mostafa","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13956-BIB0070|bjd13956-cit-0070","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1524-4725.2009.01156.x","article-title":"Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea","volume":"35","author":"Neuhaus","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1111\/bjd.13956-BIB0071|bjd13956-cit-0071","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2133.1983.tb03972.x","article-title":"Treatment of rosacea with 1% metronidazole cream. A double-blind study","volume":"108","author":"Nielsen","year":"1983a","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0072|bjd13956-cit-0072","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1983.tb03993.x","article-title":"A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea","volume":"109","author":"Nielsen","year":"1983b","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0073|bjd13956-cit-0073","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(76)92160-7","article-title":"Treatment of rosacea by metronidazole","volume":"1","author":"Pye","year":"1976","journal-title":"Lancet"},{"key":"10.1111\/bjd.13956-BIB0074|bjd13956-cit-0074","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1468-3083.2005.01248.x","article-title":"Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea","volume":"19","author":"Rigopoulos","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13956-BIB0075|bjd13956-cit-0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.1980.tb06558.x","article-title":"A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea","volume":"102","author":"Saihan","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0076|bjd13956-cit-0076","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2005.04.069","article-title":"A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"53","author":"Sanchez","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0077|bjd13956-cit-0077","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/09546639709160276","article-title":"The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study","volume":"8","author":"Sauder","year":"1997","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.13956-BIB0078|bjd13956-cit-0078","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF03259568","article-title":"Comparison of metronidazole 1% cream versus oral tetracycline in patients with rosacea","volume":"3","author":"Schachter","year":"1991","journal-title":"Drug Invest"},{"key":"10.1111\/bjd.13956-BIB0079|bjd13956-cit-0079","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Adv Ther"},{"key":"10.1111\/bjd.13956-BIB0080|bjd13956-cit-0080","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-4632.2006.02944.x","article-title":"Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study","volume":"45","author":"Sharquie","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0081|bjd13956-cit-0081","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.1966.tb12168.x","article-title":"A clinical trial of tetracycline in rosacea","volume":"78","author":"Sneddon","year":"1966","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0082|bjd13956-cit-0082","first-page":"529","article-title":"Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea","volume":"6","author":"Tan","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/bjd.13956-BIB0083|bjd13956-cit-0083","first-page":"541","article-title":"Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea","volume":"7","author":"Thiboutot","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0084|bjd13956-cit-0084","first-page":"639","article-title":"A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance therapy","volume":"8","author":"Thiboutot","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0085|bjd13956-cit-0085","first-page":"357","article-title":"Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea","volume":"75","author":"Torok","year":"2005","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0086|bjd13956-cit-0086","first-page":"209","article-title":"Topical metronidazole in the treatment of rosacea","volume":"38","author":"Veien","year":"1986","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0087|bjd13956-cit-0087","first-page":"472","article-title":"Comparative study of topical erythromycin and topical metronidazole in the treatment of rosacea","volume":"9","author":"Verea Hernando","year":"1992","journal-title":"Farm Clin"},{"key":"10.1111\/bjd.13956-BIB0088|bjd13956-cit-0088","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"Br J Dermatol"},{"issue":"Suppl. 4","key":"10.1111\/bjd.13956-BIB0089|bjd13956-cit-0089","first-page":"3","article-title":"Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea","volume":"77","author":"Wolf","year":"2006","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0090|bjd13956-cit-0090","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2013.04.015","article-title":"Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: a double-blind randomized controlled trial","volume":"69","author":"Alam","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13956-BIB0091|bjd13956-cit-0091","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-4632.2011.05353.x","article-title":"Randomized, double-blind trial of 220\u00a0mg zinc sulfate twice daily in the treatment of rosacea","volume":"51","author":"Bamford","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0092|bjd13956-cit-0092","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1473-2165.2011.00598.x","article-title":"Clinical and instrumental assessment of the effects of a new product based on hydroxypropyl chitosan and potassium azeloyl diglycinate in the management of rosacea","volume":"11","author":"Berardesca","year":"2012","journal-title":"J Cosmet Dermatol"},{"key":"10.1111\/bjd.13956-BIB0093|bjd13956-cit-0093","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/ijd.12552","article-title":"Clinical and experimental assessment of the effects of a new topical treatment with praziquantel in the management of rosacea","volume":"54","author":"Bribeche","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0094|bjd13956-cit-0094","first-page":"333","article-title":"A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12\u00a0weeks","volume":"11","author":"Chang","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0095|bjd13956-cit-0095","first-page":"607","article-title":"Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40\u00a0mg versus metronidazole gel 1% plus oral doxycycline 40\u00a0mg in mild-to-moderate papulopustular rosacea","volume":"9","author":"Del Rosso","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0096|bjd13956-cit-0096","first-page":"306","article-title":"Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study","volume":"92","author":"Draelos","year":"2013b","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0097|bjd13956-cit-0097","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","article-title":"Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies","volume":"166","author":"Fowler","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0098|bjd13956-cit-0098","first-page":"650","article-title":"Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies","volume":"12","author":"Fowler","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0099|bjd13956-cit-0099","first-page":"505","article-title":"Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study","volume":"8","author":"Gollnick","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.13956-BIB0100|bjd13956-cit-0100","first-page":"308","article-title":"Clinical research of topical tacrolimus ointment combined with 585\u00a0nm pulsed dye laser in the treatment of rosacea [Chinese]","volume":"41","author":"Huang","year":"2012","journal-title":"J Clin Dermatol"},{"key":"10.1111\/bjd.13956-BIB0101|bjd13956-cit-0101","first-page":"292","article-title":"Efficacy of extended-release 45\u00a0mg oral minocycline and extended-release 45\u00a0mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea","volume":"12","author":"Jackson","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0102|bjd13956-cit-0102","doi-asserted-by":"crossref","first-page":"A181","DOI":"10.1016\/j.jval.2014.03.1059","article-title":"A comparison of 3 assessments in the treatment of rosacea in the context of a comparative effectiveness study","volume":"17","author":"Kendall","year":"2014","journal-title":"Value Health"},{"key":"10.1111\/bjd.13956-BIB0103|bjd13956-cit-0103","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1346-8138.2010.00999.x","article-title":"Enhancing effect of pretreatment with topical niacin in the treatment of rosacea-associated erythema by 585-nm pulsed dye laser in Koreans: a randomized, prospective, split-face trial","volume":"38","author":"Kim","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0104|bjd13956-cit-0104","first-page":"1179","article-title":"Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study","volume":"10","author":"Leyden","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0105|bjd13956-cit-0105","first-page":"685","article-title":"Randomized, phase 2, dose-ranging study in the treatment of rosacea with encapsulated benzoyl peroxide gel","volume":"13","author":"Leyden","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0106|bjd13956-cit-0106","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jdv.12520","article-title":"A multicentre, randomized, placebo-controlled trial establishing the treatment effect of TDT 068, a topical formulation containing drug-free ultra-deformable phospholipid vesicles, on the primary features of erythematotelangiectatic rosacea","volume":"29","author":"Luger","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13956-BIB0107|bjd13956-cit-0107","unstructured":"NCT01426269. Evaluation of relapse, efficacy and safety of long-term treatment with Oracea \u00ae capsules compared to placebo after an initial 12\u00a0week treatment regimen with Oracea \u00ae and MetroGel \u00ae 1% in adults with rosacea https:\/\/clinicaltrials.gov\/"},{"key":"10.1111\/bjd.13956-BIB0108|bjd13956-cit-0108","unstructured":"NCT01449591. A proof of concept (PoC) study to evaluate the safety, tolerability, and efficacy of 12\u00a0week administration of BFH772 ointment in rosacea patients https:\/\/clinicaltrials.gov\/"},{"key":"10.1111\/bjd.13956-BIB0109|bjd13956-cit-0109","unstructured":"NCT01885000. Patient-reported outcome of facial erythema (PROOF)"},{"key":"10.1111\/bjd.13956-BIB0110|bjd13956-cit-0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1468-3083.2009.03357.x","article-title":"Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial","volume":"24","author":"Nymann","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13956-BIB0111|bjd13956-cit-0111","first-page":"126","article-title":"A comparative, double-blind study about efficacy and safety of crotamiton vs benzyl benzoate in the treatment of rosacea with demodecidosis","volume":"47","author":"Rodr\u00edguez Acar","year":"2003","journal-title":"Dermatol Rev Mex"},{"key":"10.1111\/bjd.13956-BIB0112|bjd13956-cit-0112","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijid.2012.11.022","article-title":"Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum","volume":"17","author":"Salem","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1111\/bjd.13956-BIB0113|bjd13956-cit-0113","first-page":"920","article-title":"Management of rosacea-prone skin: evaluation of a skincare product containing Ambophenol, Neurosensine, and La Roche-Posay thermal spring water as monotherapy or adjunctive therapy","volume":"12","author":"Seit\u00e9","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0114|bjd13956-cit-0114","first-page":"316","article-title":"Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies","volume":"13","author":"Stein","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13956-BIB0115|bjd13956-cit-0115","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/bjd.13408","article-title":"Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial","volume":"172","author":"Taieb","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13956-BIB0116|bjd13956-cit-0116","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1248\/cpb.60.583","article-title":"Preparation and evaluation of topical microemulsion system containing metronidazole for remission in rosacea","volume":"60","author":"Tirnaksiz","year":"2012","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1111\/bjd.13956-BIB0117|bjd13956-cit-0117","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/jid.2013.472","article-title":"Reduction in serine protease activity correlates with improved rosacea severity in a small, randomized pilot study of a topical serine protease inhibitor","volume":"134","author":"Two","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13956-BIB0118|bjd13956-cit-0118","first-page":"277","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents","volume":"92","author":"Del Rosso","year":"2013b","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0119|bjd13956-cit-0119","first-page":"18","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies","volume":"93","author":"Del Rosso","year":"2014a","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0120|bjd13956-cit-0120","first-page":"71","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: a status report on physical modalities and devices","volume":"93","author":"Tanghetti","year":"2014","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0121|bjd13956-cit-0121","first-page":"134","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea","volume":"93","author":"Del Rosso","year":"2014b","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0122|bjd13956-cit-0122","first-page":"234","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care","volume":"92","author":"Del Rosso","year":"2013c","journal-title":"Cutis"},{"key":"10.1111\/bjd.13956-BIB0123|bjd13956-cit-0123","first-page":"768","article-title":"Rosacea - S1 guideline","volume":"11","author":"Reinholz","year":"2013","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13956","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13956","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13956\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T17:11:39Z","timestamp":1717953099000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/173\/3\/651\/6627487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,30]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13956","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,30]]}}}